Senior biopharma executive with nearly 20 years of strategy, operational and business development experience will help lead Replicate's corporate strategy, partnerships and next chapter of growth SAN ...

Add Decrypt as your preferred source to see more of our stories on Google. Buzzy recently launched with a tool that analyzes viral videos and remixes user content for social platforms. The company ...

Under the agreement, Instituto Butantan will conduct registrational clinical trials of Replicate's novel srRNA rabies vaccine for post-exposure and pre-exposure prophylaxis Replicate to provide GMP ...

Cloudflare Inc. has acquired Replicate Inc., a startup with software that makes it easier to deploy artificial intelligence models in production. The companies announced the transaction today without ...

Cloudflare (NET) announced it has reached an agreement to acquire Replicate, which will give developers on its Workers platform access to tens of thousands of artificial intelligence models. Replicate ...

SAN FRANCISCO--(BUSINESS WIRE)--Cloudflare, Inc. (NYSE: NET), the leading connectivity cloud company, today announced it has agreed to acquire Replicate, an AI platform that makes it easy for ...

I am currently reading Pascal Bornet’s Irreplaceable: The Art of Standing Out in the Age of Artificial Intelligence. In this book, Bornet introduces a concept he calls Humics: a set of uniquely human ...

Novo Nordisk agreed to collaborate with Replicate Biosciences to develop potential new treatments for obesity, type 2 diabetes and other cardiometabolic diseases, as it grapples with mounting ...

Aug 28 (Reuters) - Replicate Bioscience will partner with Novo Nordisk (NOVOb.CO), opens new tab to develop treatments using self-replicating RNA technology for obesity, type 2 diabetes and other ...

Novo Nordisk has both internal research and external alliances pursuing new drugs that could shape the next generation of metabolic medicines. The pharmaceutical giant’s latest move is a partnership ...

As obesity pioneer Novo Nordisk loses ground in the race for next-generation drugs, the Danish pharma giant is betting on novel RNA technology to bolster its early-stage pipeline. Novo has inked a ...

Novo vaulted into the ranks of the world’s most valuable drugmakers in recent years after introducing Ozempic for diabetes and Wegovy for obesity. Rival Eli Lilly had similar success with its entrants ...